跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 2026-09-30AI 评分9

AbbVie 湿疹药物展现 II 期疗效;BioMarin 裁员 117 人

AbbVie's eczema drug shows benefit in Phase 2; BioMarin lays off 117

AI 导读

AbbVie 公布其治疗湿疹药物的 II 期数据,显示临床获益。BioMarin 宣布裁员 117 人。Sarepta、Rafael Holdings、Sagimet 等多家生物医药公司亦有相关动态。

正文

Plus news about Sarep­ta, Rafael Hold­ings, Sagimet, Pyx­is On­col­o­gy, Con­nect Bio­phar­ma, Asahi Ka­sei, As­tro­cyte Phar­ma­ceu­ti­cals, GSK, Wave and Kail­era.

Ab­b­Vie un­veils Phase 2 da­ta for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news